• Emma Salib (chair)

• Vanessa Acquaah (programme manager)

• Philani Mpofu (Lead Methodologist)

• Jennifer McCaffery (lay)

• Hayley Hall (lay)

• Sonia Patton (patient)

• Trishna Bhadaria (patient)

• Shira Peleg-Hasson (clinical)

No conflicts declared by panel

Approved

• The feedback consistently highlighted that the lay summary was well written   
  and provided a clear overview of the research institution, disease area, and   
  rationale for the study.

• There was clear potential for the work to benefit patients.

• The research aims, methodology and benefits were very clearly outlined.

• The panel raised several comments on other aspects of the application   
  including:

  • The panel enquired about future opportunities to explore similar   
    research in other breast cancer patient populations.

    • It was noted that leveraging real-world data (RWD) in future   
      studies, such as this one, could enable researchers to identify   
      and explore important characteristics of breast cancer in other   
      populations, supporting more inclusive and comprehensive   
      research across diverse patient populations.

  • The group discussed further ideas to unveil overall disease burden to   
    understand patient outcomes (e.g. looking at location of metastases).

  • It was discussed that the researchers certainly had the intention   
    of investigating such areas further and would review this   
    closely.